We then measured the expression level of METTL3 in tumor tissues of 96 ICC patients by immunohistochemistry (IHC) staining (Fig. 1D) and compared the correlation between METTL3 expression and clinical characteristics (Supplementary Table 1). This evidence concerns the gene METTL3 and intrahepatic cholangiocarcinoma.